| Literature DB >> 29476442 |
Francesco Nicita1, Giorgio Tasca2, Marta Nardella1, Emanuele Bellacchio3, Ilaria Camponeschi1, Gessica Vasco4, Tommaso Schirinzi4, Enrico Bertini1, Ginevra Zanni5.
Abstract
Mutations in KCNJ10, which encodes the inwardly rectifying potassium channel Kir4.1, a primary regulator of membrane excitability and potassium homeostasis, cause a complex syndrome characterized by seizures, sensorineural deafness, ataxia, intellectual disability, and electrolyte imbalance called SeSAME/EAST syndrome. We describe a 41-year-old patient with non-syndromic, slowly progressive, early-onset ataxia. Targeted next-generation sequencing identified a novel c.180 T > G (p.Ile60Met) missense homozygous mutation. The mutated residue Ile60Met likely impairs phosphatidylinositol 4, 5-bisphosphate (PIP2) binding which is known to play an essential role in channel gating. Our study expands the clinical and mutational spectrum of KCNJ10-related disorders and suggests that screening of this gene should be implemented in patients with early-onset ataxia, with or without syndromic features.Entities:
Keywords: Ataxia; EAST syndrome; Epilepsy; KCNJ10; Kir4.1; Phosphatidylinositol 4, 5-bisphosphate (PIP2)
Mesh:
Substances:
Year: 2018 PMID: 29476442 DOI: 10.1007/s12311-018-0924-7
Source DB: PubMed Journal: Cerebellum ISSN: 1473-4222 Impact factor: 3.847